These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11425528)

  • 21. 5'-O-fluorosulfonylbenzoyl esters of purine nucleosides as potential inhibitors of NTPase/helicase and polymerase of Flaviviridae viruses.
    Bretner M; Schalinski S; Borowski P; Kulikowski T
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1531-3. PubMed ID: 14565459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triaminotriazine DNA helicase inhibitors with antibacterial activity.
    McKay GA; Reddy R; Arhin F; Belley A; Lehoux D; Moeck G; Sarmiento I; Parr TR; Gros P; Pelletier J; Far AR
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1286-90. PubMed ID: 16343901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of DNA helicases with DNA-competitive inhibitors.
    Dubaele S; Jahnke W; Schoepfer J; Fuchs J; Chène P
    Bioorg Med Chem Lett; 2006 Feb; 16(4):923-7. PubMed ID: 16300943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparisons between the structures of HCV and Rep helicases reveal structural similarities between SF1 and SF2 super-families of helicases.
    Korolev S; Yao N; Lohman TM; Weber PC; Waksman G
    Protein Sci; 1998 Mar; 7(3):605-10. PubMed ID: 9541392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the helicase activity of the HCV NS3 protein by symmetrical dimeric bis-benzimidazoles.
    Tunitskaya VL; Mukovnya AV; Ivanov AA; Gromyko AV; Ivanov AV; Streltsov SA; Zhuze AL; Kochetkov SN
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5331-5. PubMed ID: 21821416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fragment-Based Discovery of Dual JC Virus and BK Virus Helicase Inhibitors.
    Bonafoux D; Nanthakumar S; Bandarage UK; Memmott C; Lowe D; Aronov AM; Bhisetti GR; Bonanno KC; Coll J; Leeman J; Lepre CA; Lu F; Perola E; Rijnbrand R; Taylor WP; Wilson D; Zhou Y; Zwahlen J; Ter Haar E
    J Med Chem; 2016 Aug; 59(15):7138-51. PubMed ID: 27385654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docking ligands into flexible and solvated macromolecules. 2. Development and application of fitted 1.5 to the virtual screening of potential HCV polymerase inhibitors.
    Corbeil CR; Englebienne P; Yannopoulos CG; Chan L; Das SK; Bilimoria D; L'heureux L; Moitessier N
    J Chem Inf Model; 2008 Apr; 48(4):902-9. PubMed ID: 18341269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heliquinomycin, a new inhibitor of DNA helicase, produced by Streptomyces sp. MJ929-SF2 II. Structure determination of heliquinomycin.
    Chino M; Nishikawa K; Tsuchida T; Sawa R; Nakamura H; Nakamura KT; Muraoka Y; Ikeda D; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1997 Feb; 50(2):143-6. PubMed ID: 9099224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical methods to determine the binding mode of putative ligands for hepatitis C virus NS3 helicase.
    Sarver RW; Rogers JM; Stockman BJ; Epps DE; DeZwaan J; Harris MS; Baldwin ET
    Anal Biochem; 2002 Oct; 309(2):186-95. PubMed ID: 12413450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based discovery of triphenylmethane derivatives as inhibitors of hepatitis C virus helicase.
    Chen CS; Chiou CT; Chen GS; Chen SC; Hu CY; Chi WK; Chu YD; Hwang LH; Chen PJ; Chen DS; Liaw SH; Chern JW
    J Med Chem; 2009 May; 52(9):2716-23. PubMed ID: 19419203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel hepatitis C virus protease inhibitors: thiazolidine derivatives.
    Sudo K; Matsumoto Y; Matsushima M; Fujiwara M; Konno K; Shimotohno K; Shigeta S; Yokota T
    Biochem Biophys Res Commun; 1997 Sep; 238(2):643-7. PubMed ID: 9299567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTPase/helicase of Flaviviridae: inhibitors and inhibition of the enzyme.
    Borowski P; Niebuhr A; Schmitz H; Hosmane RS; Bretner M; Siwecka MA; Kulikowski T
    Acta Biochim Pol; 2002; 49(3):597-614. PubMed ID: 12422230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
    Braun S; Botzki A; Salmen S; Textor C; Bernhardt G; Dove S; Buschauer A
    Eur J Med Chem; 2011 Sep; 46(9):4419-29. PubMed ID: 21803461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication.
    Najda-Bernatowicz A; Krawczyk M; Stankiewicz-Drogoń A; Bretner M; Boguszewska-Chachulska AM
    Bioorg Med Chem; 2010 Jul; 18(14):5129-36. PubMed ID: 20579888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single strand binding proteins increase the processivity of DNA unwinding by the hepatitis C virus helicase.
    Rajagopal V; Patel SS
    J Mol Biol; 2008 Feb; 376(1):69-79. PubMed ID: 18155046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of HCV NS3 and NS5B proteins to support small-molecule drug discovery.
    Hung M; Wang R; Liu X
    Curr Protoc Pharmacol; 2011 Sep; Chapter 13():Unit13B.6. PubMed ID: 21898331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Searching for a new anti-HCV therapy: synthesis and properties of tropolone derivatives.
    Boguszewska-Chachulska AM; Krawczyk M; Najda A; Kopańska K; Stankiewicz-Drogoń A; Zagórski-Ostoja W; Bretner M
    Biochem Biophys Res Commun; 2006 Mar; 341(2):641-7. PubMed ID: 16438939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationship studies of a bisbenzimidazole-based, Zn(2+)-dependent inhibitor of HCV NS3 serine protease.
    Yeung KS; Meanwell NA; Qiu Z; Hernandez D; Zhang S; McPhee F; Weinheimer S; Clark JM; Janc JW
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2355-9. PubMed ID: 11527730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probing the relationship between RNA-stimulated ATPase and helicase activities of HCV NS3 using 2'-O-methyl RNA substrates.
    Hesson T; Mannarino A; Cable M
    Biochemistry; 2000 Mar; 39(10):2619-25. PubMed ID: 10704211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New acridone-4-carboxylic acid derivatives as potential inhibitors of hepatitis C virus infection.
    Stankiewicz-Drogon A; Palchykovska LG; Kostina VG; Alexeeva IV; Shved AD; Boguszewska-Chachulska AM
    Bioorg Med Chem; 2008 Oct; 16(19):8846-52. PubMed ID: 18801660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.